BridgeBio Pharma (BBIO) Gross Profit (2020 - 2026)
BridgeBio Pharma's Gross Profit was $228.63 million in Q2 2026, up 113.8% from $106.91 million a year earlier and up 23.9% from the prior quarter.
Powered by 
Analysis
BridgeBio Pharma (BBIO) Gross Profit (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, BridgeBio Pharma's Gross Profit was $673.41 million through Jun 30, 2026, up 196.9% year-over-year; for FY2025, it was $481.11 million, up 120.7% from FY2024.
- Gross Profit shows a five-year compound annual growth rate of 125.5% (FY2020 to FY2025).
- In earlier years, Gross Profit was $218.02 million in FY2024, $6.86 million in FY2023 (-90.8%), $74.21 million in FY2022 (+11.4%) and $66.6 million in FY2021 (+707.4%).
- The Q2 2026 figure marks the highest quarterly Gross Profit in data going back to Q3 2020.
- Compared with a year earlier, Gross Profit was higher in three of the last five quarters, with growth averaging 64.4%.
- The best year-over-year quarter for Gross Profit over five years was Q1 2023 (growth of 239.6%); the worst was Q2 2023 (a decline of 98.6%).
- Per Business Quant data, BBIO's Gross Profit in the three quarters before Q2 2026 was $184.58 million (Q1 2026), $146.07 million (Q4 2025) and $114.14 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | BridgeBio Pharma | 13.13 Bn | 10.25 Bn | 228.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 228.63 Mn |
| Mar 31, 2026 | 184.58 Mn |
| Dec 31, 2025 | 146.07 Mn |
| Sep 30, 2025 | 114.14 Mn |
| Jun 30, 2025 | 106.91 Mn |
| Mar 31, 2025 | 113.99 Mn |
| Dec 31, 2024 | 3.80 Mn |
| Sep 30, 2024 | 2.13 Mn |
| Jun 30, 2024 | 1.57 Mn |
| Mar 31, 2024 | 210.52 Mn |
| Dec 31, 2023 | 1.15 Mn |
| Sep 30, 2023 | 3.49 Mn |
| Jun 30, 2023 | 1.04 Mn |
| Mar 31, 2023 | 1.18 Mn |
| Dec 31, 2022 | 1.22 Mn |
| Sep 30, 2022 | -401,000.00 |
| Jun 30, 2022 | 73.05 Mn |
| Mar 31, 2022 | 346,000.00 |
| Dec 31, 2021 | 11.34 Mn |
| Sep 30, 2021 | 890,000.00 |
API Access
BridgeBio Pharma Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=BBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();